Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
- 20 July 2013
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 36 (10) , 953-980
Abstract
Allopurinol is the primary therapy for the management of chronic gout. Utilization of allopurinol has increased in tandem with the growing prevalence of gout globally. This exposes more patients to the risk of allopurinol hypersensitivity (AH), a rare adverse reaction characterised by a spectrum of cutaneous reactions and systemic manifestations. Severe forms of AH have been associated with high mortality. The pathophysiology underlying this reaction remains unknown, but several risk factors have been proposed.Keywords
This publication has 431 references indexed in Scilit:
- Cross-sectional and longitudinal associations between serum uric acid and metabolic syndromeEndocrine, 2012
- Drug hypersensitivity: Pharmacogenetics and clinical syndromesJournal of Allergy and Clinical Immunology, 2011
- A potentially fatal cause of rashInternational Journal of Emergency Medicine, 2010
- Medication Adherence of Patients with Selected Rheumatic Conditions: A Systematic Review of the LiteratureSeminars in Arthritis and Rheumatism, 2009
- The Janus Faces of Allopurinol—Allopurinol Hypersensitivity SyndromeThe American Journal of Medicine, 2008
- Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR StudyJournal of the American Academy of Dermatology, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Quality of care for gout in the US needs improvementArthritis Care & Research, 2007
- The allopurinol hypersensitivity syndromeJournal of the American Academy of Dermatology, 1979
- Allopurinol-induced granulomatous hepatitisDigestive Diseases and Sciences, 1976